The 9th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference is dedicated to the gaps between early-stage biomarker development and the commercialization stage of biomarkers.
The 9th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference covers topics such as:
- Proteomics and Genomics based Biomarkers
- Commercialization of CDx
- Multiplex Companion Diagnostics and Regulatory Guidelines
- Biomarker Drug Discovery and Assay Development
- Digital Biomarkers, Predictive Biomarkers, Precision Medicine and Big Data
- Design of clinical trials in CDx
- Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases
The 9th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference brings together attendees from:
- Bio-pharma companies
- Pharmaceutical companies
- Universities and Research institutes
Working in:
- Translational research
- Biomarker discovery/development
- Biomarkers in IO and Neurological disorders
- Clinical Biomarker
- Pathology
- Imaging Biomarkers
- Biomarker Imaging
- Companion Diagnostics
- Experimental Medicine
- Proteomics Biomarkers
- Biomarkers in Clinical Discovery
- Data Science
- Diagnostic Biomarkers development
- Immuno-oncology/Neuroscience Drug Discovery
- Immunology Biomarkers
- Personalized Medicine
